tiprankstipranks
Dermata Therapeutics (DRMA)
NASDAQ:DRMA
US Market

Dermata Therapeutics (DRMA) Financial Statements

63 Followers

Dermata Therapeutics Financial Overview

Dermata Therapeutics's market cap is currently ―. The company's EPS TTM is $-32.722; its P/E ratio is -0.06; Dermata Therapeutics is scheduled to report earnings on September 23, 2024, and the estimated EPS forecast is $-3.79. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Dec 23Sep 23Jun 23Mar 23
Income Statement-
Total Revenue$ 6.90M----
Gross Profit$ 6.90M----
EBIT$ -3.13M$ -2.22M$ -1.81M$ -1.73M$ -2.28M
EBITDA$ -3.13M$ -2.22M$ -1.81M$ -1.73M$ -2.28M
Net Income Common Stockholders$ -3.13M$ -2.13M$ -1.72M$ -1.70M$ -2.24M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 0.00$ 0.00$ 6.63M$ 8.44M$ 8.77M
Total Assets$ 5.18M$ 7.98M$ 7.32M$ 8.71M$ 9.30M
Total Debt$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Net Debt$ 0.00$ 0.00$ -6.63M$ -8.44M$ -8.77M
Total Liabilities$ 1.37M$ 1.62M$ 916.82K$ 682.86K$ 1.21M
Stockholders Equity$ 3.81M$ 6.36M$ 6.41M$ 8.03M$ 8.09M
Cash Flow-
Free Cash Flow$ -2.70M$ -1.15M$ -1.77M$ -1.84M$ -1.65M
Operating Cash Flow$ -2.70M$ -1.15M$ -1.77M$ -1.84M$ -1.65M
Investing Cash Flow-----
Financing Cash Flow-$ 1.95M$ -35.42K$ 1.51M$ 4.18M
Currency in USD

Dermata Therapeutics Earnings and Revenue History

Dermata Therapeutics Debt to Assets

Dermata Therapeutics Cash Flow

Dermata Therapeutics Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis